• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eyepoint Pharmaceuticals Inc (NQ: EYPT )

    9.190 +0.190 (+2.11%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 665,533
    Open 9.020
    Bid (Size) 9.000 (2)
    Ask (Size) 9.700 (3)
    Prev. Close 9.000
    Today's Range 8.995 - 9.590
    52wk Range 5.670 - 30.99
    Shares Outstanding 34,984,044
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
    Via Benzinga
    Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    -59.19%
    -59.19%
    1 Month
    +0.33%
    +0.33%
    3 Month
    -17.65%
    -17.65%
    6 Month
    -65.38%
    -65.38%
    1 Year
    -20.16%
    -20.16%

    More News

    Read More
    Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
    Via Benzinga
    Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
    Via Benzinga
    A Preview Of EyePoint Pharmaceuticals's Earnings
    Via Benzinga
    Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals
    Via Benzinga
    Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
    Via Benzinga
    Exposures Fossil Fuels
    Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga
    EYPT Stock Earnings: EyePoint Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    The 3 Most Promising Stocks to Invest in Before They Take Off
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration
    From EyePoint Pharmaceuticals, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.